Apr 20, 2016

Posted by in Stock Reports | 0 Comments

Significant Insider Buying Activity: Inovio Pharmaceuticals Inc (NASDAQ:INO), Akamai Technologies, Inc. (NASDAQ:AKAM), Opko Health Inc. (NYSE:OPK)

Significant Insider Buying Activity: Inovio Pharmaceuticals Inc (NASDAQ:INO), Akamai Technologies, Inc. (NASDAQ:AKAM), Opko Health Inc. (NYSE:OPK)

Insider trading is the trading of a public company’s stock or other securities (such as bonds or stock options) by individuals with access to nonpublic information about the company. In various countries, trading based on insider information is illegal. This is because it is seen as unfair to other investors who do not have access to the information as the investor with insider information could potentially make far larger profits that a typical investor could not make.

The authors of one study claim that illegal insider trading raises the cost of capital for securities issuers, thus decreasing overall economic growth. However, some economists have argued that insider trading should be allowed and could, in fact, benefit markets.

Trading by specific insiders, such as employees, is commonly permitted as long as it does not rely on material information not in the public domain. However, most jurisdictions require such trading be reported so that these can be monitored. In the United States and several other jurisdictions, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade.

Moving on to the first insider trade Apr 15, 2016 which involved COLLINS MORTON, a director at Inovio Pharmaceuticals Inc (NASDAQ:INO), who acquired 68,400 shares at $9.52 per share to put the total holding at 64,750 shares. Its shares currently owned by company management are 3.80% while institutional investors own about 32.70%. The 6-month change recorded in total insider ownership was 2.54%. On the other side, -0.07% change in total institutional ownership has been reported for the 3-month period.

Akamai Technologies, Inc. (NASDAQ:AKAM) saw an insider buy stock in the company on Apr 15. LEIGHTON F THOMSON, Chief Executive Officer of the company, bought 19,546 shares for $51.15 per share worth a total of $999,778. After this insider buying, LEIGHTON F THOMSON now has a total stake of 3,017,656 shares in the company. Its shares currently owned by company management are 0.20% while institutional investors own about 85.00%. The 6-month change recorded in total insider ownership was -25.27%. On the other side, -5.95% change in total institutional ownership has been reported for the 3-month period.

Opko Health Inc. (NYSE:OPK) also received some insider trading action as FROST PHILLIP MD ET AL, who is the company’s CEO & Chairman added some 7,600 shares at a price of $10.78 per share to the holding that now comprises of 159,480,443 shares. Its shares currently owned by company management are 6.20% while institutional investors own about 21.20%. The 6-month change recorded in total insider ownership was 4.82%.

 

 

 

 

 

 

Comments are closed.